These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35629385)

  • 1. Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Theofilis P; Vordoni A; Nakas N; Kalaitzidis RG
    Life (Basel); 2022 May; 12(5):. PubMed ID: 35629385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
    Colak Y; Senates E; Yesil A; Yilmaz Y; Ozturk O; Doganay L; Coskunpinar E; Kahraman OT; Mesci B; Ulasoglu C; Tuncer I
    Endocrine; 2013 Feb; 43(1):100-7. PubMed ID: 22661277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease.
    Pugh CJ; Spring VS; Kemp GJ; Richardson P; Shojaee-Moradie F; Umpleby AM; Green DJ; Cable NT; Jones H; Cuthbertson DJ
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(9):H1298-306. PubMed ID: 25193471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes.
    Montazeri Z; Hashemi-Madani N; Iraji H; Sohrabi M; Alaei-Shahmiri F; Emami Z; Babaei MR; Malek M; Khamseh ME
    BMC Endocr Disord; 2023 Sep; 23(1):202. PubMed ID: 37749528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk.
    Al-Hamoudi W; Alsadoon A; Hassanian M; Alkhalidi H; Abdo A; Nour M; Halwani R; Sanai F; Alsharaabi A; Alswat K; Hersi A; Albenmousa A; Alsaif F
    Sci Rep; 2020 Jun; 10(1):8825. PubMed ID: 32483260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Anania C; Martino F; Cantisani V; Pascone R; Marcantonio A; Chiesa C
    Hepatology; 2010 Nov; 52(5):1643-51. PubMed ID: 20890890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Makri E; Orfanidou M; Makri ES; Goulas A; Terpos E; Polyzos SA
    J Clin Exp Hepatol; 2024; 14(3):101353. PubMed ID: 38435724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors.
    Pastori D; Loffredo L; Perri L; Baratta F; Scardella L; Polimeni L; Pani A; Brancorsini M; Albanese F; Catasca E; Del Ben M; Violi F; Angelico F
    Am J Cardiol; 2015 May; 115(10):1402-6. PubMed ID: 25776455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Zhou Z; Chen H; Ju H; Sun M
    Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
    Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
    Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD.
    Sapmaz F; Uzman M; Basyigit S; Ozkan S; Yavuz B; Yeniova A; Kefeli A; Asilturk Z; Nazligül Y
    Medicine (Baltimore); 2016 Apr; 95(14):e3280. PubMed ID: 27057890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Han D; Chen J; Liu S; Zhang Z; Zhao Z; Jin W; Xin Y
    J Clin Transl Hepatol; 2021 Aug; 9(4):484-493. PubMed ID: 34447677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
    Li F; Ye J; Shao C; Zhong B
    Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis.
    Mahfood Haddad T; Hamdeh S; Kanmanthareddy A; Alla VM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S209-S216. PubMed ID: 28017631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating irisin in nonalcoholic fatty liver disease: an updated meta-analysis.
    Qiu S; Wang Q; Cai X; Sun Z; Wu T
    Endokrynol Pol; 2023; 74(1):47-54. PubMed ID: 36094873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.